CVE:RLV Relevium Technologies (RLV) Stock Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free RLV Stock Alerts C$0.02 0.00 (0.00%) (As of 01/7/2022) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.05Volume130,500 shsAverage Volume140,861 shsMarket CapitalizationC$6.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Relevium Technologies alerts: Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Relevium TechnologiesRelevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.Read More RLV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RLV Stock News HeadlinesOctober 17, 2023 | investing.comRelevium Technologies Inc (RLVh)August 11, 2022 | yahoo.comDru Hill’s Sisqo Responds To Jodeci ‘Verzuz’ Battle DebateApril 29, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…February 11, 2022 | yahoo.comRelevium Provides Operational and Continued Disclosure UpdateJanuary 5, 2022 | finance.yahoo.comRelevium Provides Bi-Weekly Update to Management Cease Trade OrderDecember 18, 2021 | financialpost.comRelevium Provides Bi-Weekly Update to Management Cease Trade Order and Shares for Debt SettlementNovember 19, 2021 | finance.yahoo.comRelevium Provides Update to Management Cease Trade Order and Other MattersNovember 1, 2021 | finance.yahoo.comRelevium Announces Delay in Filing Annual Financial StatementsApril 29, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)October 26, 2021 | finance.yahoo.comRelevium Provides Corporate Update on the Transaction to Acquire BioganixOctober 1, 2021 | finance.yahoo.comRelevium Technologies Completes Shares-For-Debt TransactionsAugust 12, 2021 | au.finance.yahoo.comUPDATE 1-Robinhood to buy fintech firm Say Technologies for $140 mlnAugust 10, 2021 | financialpost.comRelevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in SharesSee More Headlines Receive RLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relevium Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolCVE:RLV CUSIPN/A CIKN/A Webwww.releviumcorp.com Phone+1-514-8248559FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,640,000.00 Net Margins-18.50% Pretax MarginN/A Return on EquityN/A Return on Assets4.20% Debt Debt-to-Equity Ratio8,068.50 Current Ratio0.60 Quick Ratio0.02 Sales & Book Value Annual SalesC$14.25 million Price / Sales0.46 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares329,490,000Free FloatN/AMarket CapC$6.59 million OptionableNot Optionable Beta1.88 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Aurelio Useche C.M.A. (Age 55)M.B.A., Pres, CEO & Director Comp: $184.42kMr. Mark Anthony Billings C.F.A. (Age 53)CFA, M.B.A., MBA, Chief Financial Officer Comp: $64kMr. Edward Ierfino B. Comm. (Age 55)Mang. of Investor Relations Mr. Abis HussainSr. Marketing OfficerKey CompetitorsFire & FlowerTSE:FAFHarvest One CannabisCVE:HVTVoyageur PharmaceuticalsCVE:VMTitan MedicalTSE:TMDSQI DiagnosticsCVE:SQDView All Competitors RLV Stock Analysis - Frequently Asked Questions How have RLV shares performed in 2024? Relevium Technologies' stock was trading at C$0.02 at the beginning of the year. Since then, RLV stock has increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. What other stocks do shareholders of Relevium Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), Spero Therapeutics (SPRO), SoFi Weekly Income ETF (TGIF), Acquired Sales (AQSP), Aphria (APHA), Aldeyra Therapeutics (ALDX). How do I buy shares of Relevium Technologies? Shares of RLV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:RLV) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relevium Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
